Abnormal Involuntary Movement Scale (AIMS) – NRNP 6635 Discussion
In general, psychiatric assessment tools serve as a tool to determine the severity of an illness and to more effectively use medications. Abnormal Involuntary Movement Scale (AIMS) can be utilized in practice to better assess patients for tardive dyskinesia and learn more about tardive dyskinesia. The AIMS is a 12-item clinician-rated scale to assess severity of dyskinesia (specifically, orofacial movements and extremity and truncal movements) in patients taking antipsychotic and neuroleptic medications. Tardive dyskinesia is considered a late form of extrapyramidal symptoms. Jiajun and colleagues (2019) consider the occurrence of EPS being associated with poor treatment outcome of schizophrenia. Analysis shows that antipsychotics with high D2 receptor antagonistic effect and illness duration are the risk factors of EPS for individuals who suffer from schizophrenia (Jiajun et al., 2019). As a PMHNP, offering quality care is being able to assess the effectiveness and tolerability of medication using movement disorder assessment tools to help identify both the presence and severity of movements. Once the severity of tardive dyskinesia is determined, providers can consider alternative medication regimen in order to slow the process, thus improving a patient’s quality of life.
Citrome, L. (2017). Clinical management of tardive dyskinesia: Five steps to success. Journal of
the Neurological Sciences, 383, 199–204. https://doi- org.ezp.waldenulibrary.org/10.1016/j.jns.2017.11.019
College of Psychiatric & Neurologic Pharmacists. (2020). The AIMS Assessment and Tardive
Dyskinesia. Retrieved from https://cpnp.org/aims
Jiajun Weng, Yan Zhang, Huafang Li, Yifeng Shen, & Wenjuan Yu. (2019). Study on risk
factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia. Shanghai Archives of Psychiatry, 32(1), 14–21. https://doi-org.ezp.waldenulibrary.org/10.1136/gpsych-2018-100026 Abnormal Involuntary Movement Scale (AIMS) – NRNP 6635 Discussion
Thanks for your post!
When comparing the Hamilton Anxiety Rating Scale (HAM-A) to the Abnormal Involuntary Movement Scale (AIMS), the differences are most apparent. Though they are both designed to illustrate the severity of symptoms, and not necessarily to diagnose a problem, that is where the similarity ends. The HAM-A looks at symptoms of anxiety, which can be a generalized condition or a co-occurring issue that overlaps heavily with symptoms of other psychiatric conditions, such as major depression or obsessive-compulsive disorder (Hamilton, n.d.). In contrast, the AIMS scale is largely targeted at tardive dyskinesia, which is a psychiatric medication induced movement disorder. Because many dopamine blocking agents can result in involuntary movements, it is often the severity of these that determines whether the medication is continued (Montvilo, 2019). The AIMS score is compared to the benefits that client is experiencing from the medication to allow for an educated decision to be made. Abnormal Involuntary Movement Scale (AIMS) – NRNP 6635 Discussion
Hamilton, M. (n.d.). Hamilton anxiety rating scale (HAM-A). Br J Med Psychol 1959; 32:50–55. Retrieved from https://dcf.psychiatry.ufl.edu/files/2011/05/HAMILTON-ANXIETY.pdf
Montvilo, R. K. P. D. (2019). Tardive dyskinesia. Salem Press Encyclopedia of Health. Retrieved from https://ezp.waldenulibrary.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=ers&AN=97176629&site=eds-live&scope=site
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer. Abnormal Involuntary Movement Scale (AIMS) – NRNP 6635 Discussion
Is this the question you were looking for? If so, place your order here to get started!